Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07526571Not ApplicableRecruiting

GLOW Study: Effects of Triple Protein in Women

Role: collaborator

NCT07046845Not ApplicableRecruiting

Perelel Prenatal Supplements vs. Generic Prenatal Supplements and Health of Mother and Baby (SUPPORT)

Role: collaborator

NCT07303595Not ApplicableRecruiting

Mom Multi Postnatal Supplementation Trial

Role: lead

NCT07226414Not ApplicableRecruiting

Prenatal Study in Healthy Pregnant Women

Role: lead

NCT06505408Not ApplicableCompleted

Impact of a MVM to Support Biomarkers Associated With Conception and Pregnancy in Healthy Women.

Role: lead

NCT06535698Not ApplicableCompleted

Evaluating the Effect of a Supplement on Symptoms of Hormonal Imbalance.

Role: lead

All 6 trials loaded